Sox2 Cooperates with Lkb1 Loss to Promote Mouse Model of Squamous Cell Lung Cancer

被引：0
|
作者：
Mukhopadhyay, Anandaroop [1 ]
Mollaoglu, Gurkan [1 ]
Witt, Benjamin [2 ,3 ]
Oliver, Trudy G. [1 ]
机构：
[1] Huntsman Canc Inst, Oncol Sci, Salt Lake City, UT USA
[2] Univ Utah, Pathol, Salt Lake City, UT USA
[3] ARUP, Salt Lake City, UT USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Mouse model; squamous; Sox2; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL07.06
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [21] SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
    Fukazawa, Takuya
    Guo, Minzhe
    Ishida, Naomasa
    Yamatsuji, Tomoki
    Takaoka, Munenori
    Yokota, Etsuko
    Haisa, Minoru
    Miyake, Noriko
    Ikeda, Tomoko
    Okui, Tatsuo
    Takigawa, Nagio
    Maeda, Yutaka
    Naomoto, Yoshio
    SCIENTIFIC REPORTS, 2016, 6
  • [22] SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
    Takuya Fukazawa
    Minzhe Guo
    Naomasa Ishida
    Tomoki Yamatsuji
    Munenori Takaoka
    Etsuko Yokota
    Minoru Haisa
    Noriko Miyake
    Tomoko Ikeda
    Tatsuo Okui
    Nagio Takigawa
    Yutaka Maeda
    Yoshio Naomoto
    Scientific Reports, 6
  • [23] SOX2 is amplified in small-cell lung cancer
    Nature Reviews Clinical Oncology, 2012, 9 (11) : 608 - 608
  • [24] Development of a Sox2 targeting therapy for the treatment of lung squamous cell carcinoma
    Ishida, Naomasa
    Fukazawa, Takuya
    Takaoka, Munenori
    Yamatsuji, Tomoki
    Morita, Ichiro
    Haisa, Minoru
    Takaoka, Nagio
    Naomoto, Yoshio
    CANCER RESEARCH, 2015, 75
  • [25] Could Sox2 be a useful target to treat lung squamous cell carcinoma?
    Ventura, Juan-Jose
    JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : E85 - E86
  • [26] LOCALIZATION-SPECIFIC LKB1 LOSS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA METASTASIS
    Kline, Erik R.
    Muller, Susan
    Pan, Lin
    Tighiouart, Mourad
    Chen, Zhuo
    Marcus, Adam I.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (10): : 1501 - 1512
  • [27] Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
    Kitapma, Shunsuke
    Ivanova, Elena
    Guo, Sujuan
    Yoshida, Ryohei
    Campisi, Marco
    Sundararaman, Shrirarn K.
    Tange, Shoichiro
    Mitsuishi, Yoichiro
    Thai, Tran C.
    Masudaa, Sayuri
    Piel, Brandon P.
    Sholl, Lynette M.
    Kirschmeier, Paul T.
    Paweletz, Cloud P.
    Watanabe, Hideo
    Yajima, Mamiko
    Barbie, David A.
    CANCER DISCOVERY, 2019, 9 (01) : 34 - 45
  • [28] Morphologic and Clinicopathologic Features of Lung Squamous Cell Carcinomas Expressing Sox2
    Brcic, Luka
    Sherer, Carol K.
    Shuai, Yongli
    Hornick, Jason L.
    Chirieac, Lucian R.
    Dacic, Sanja
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (05) : 712 - 718
  • [29] SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
    Wilbertz, Theresia
    Wagner, Patrick
    Petersen, Karen
    Stiedl, Ann-Cathrin
    Scheble, Veit J.
    Maier, Sebastian
    Reischl, Markus
    Mikut, Ralf
    Altorki, Nasser K.
    Moch, Holger
    Fend, Falko
    Staebler, Annette
    Bass, Adam J.
    Meyerson, Matthew
    Rubin, Mark A.
    Soltermann, Alex
    Lengerke, Claudia
    Perner, Sven
    MODERN PATHOLOGY, 2011, 24 (07) : 944 - 953
  • [30] LKB1 loss sensitizes non-small cell lung cancer cells to aggravation of ER stress
    Inge, Landon J.
    Friel, Jacqueline M.
    Fowler, Aaron
    Richer, Amanda
    Whitsett, Timothy
    Tran, Nhan L.
    Bremner, Ross M.
    CANCER RESEARCH, 2014, 74 (19)
12345